home > people: core faculty > g gaudette
       

 

Glenn Gaudette 

Assistant Professor

On This Page :

  Research Focus
  Education
  Professional Experience
  Funding
  Publications
  PubMed listings
  Courses
   
   
  Related Labs + Depts
  Cardiovascular Engineering Research Lab
    

 

  Contact Info
 


Glenn Gaudette

T: 631.444.7392
F: 631.444.8963
E: glenn.gaudette@sunysb.edu
 
Office:
HSC - T18-030
Stony Brook, NY
11794-8181

   

 

 

 

 
Research Focus

Coronary artery disease generally leads to regional ischemia (no nutritive supply), resulting in a decrease in regional mechanical function. Currently, available techniques do not offer the high spatial resolution needed to determine the heterogeneous mechanical function of the heart. A method has been developed to determine regional function in the heart. This method is a whole field technique that offers high spatial resolution and is used to investigate the effects of regional ischemia on heart function. Various strategies used in the operating room to protect the heart undergoing cardiac surgery are also being investigated. This includes determining the restoration of mechanical function by angiogenesis, a process that involves new blood vessel formation.

 
Education

  • Ph.D. Biomedical Engineering State University of New York at Stony Brook 5/2002
    Dissertation Title: Determination of Regional Myocardial Function Using Computer Aided Speckle Interferometry
  • M.S. Mechanical Engineering Georgia Institute of Technology 6/1992
  • B.S. Mechanical Engineering University of Massachusetts at Dartmouth 5/1989

 
Research and Professional Experience

  • 7/02- Present Assistant Professor – Department of Biomedical Engineering. State University of New York at Stony Brook, Stony Brook, NY.
    Developed senior undergraduate biomedical engineering design course, which integrates biology and engineering. This is a two semester course and provides the student with problems ranging from molecular biosensors to organ level biomechanics. Course co-director for graduate level course. Responsible for developing a research program in cardiovascular biomechanics, which investigates clinically relevant problems at the molecular, cellular and organ level.
  • 7/02- Present Member – Institute for Molecular Cardiology. State University of New York at Stony Brook.
    Collaborated with basic scientist and clinician interesting in cardiovascular research on the molecular, cellular, and organ level.
  • 8/97- Present Director – Cardiothoracic Surgery Research. State University of New York at Stony Brook, Division of Cardiothoracic Surgery, Stony Brook, NY.
    Supervise laboratory staff that includes post-doctoral research fellows, graduate, undergraduate, and high school students. Initiated collaborations with many different research groups including biomedical engineering, mechanical engineering, physiology and biophysics.
  • 8/92-7/97 Senior Research Assistant. Harvard Medical School/Beth Israel Deaconess Medical Center, Division of Cardiothoracic Surgery, Boston, MA.
  • Responsible for daily operations of a large animal physiology laboratory. Performed cardiac surgical procedures on sheep, pigs, and rabbits. Developed acquisition and analysis techniques and programs for data interpretation. Presented results in regional and national forums.
  • 9/90-6/92 Graduate Research Assistant. Georgia Institute of Technology, Department of Mechanical Engineering, Atlanta, GA.
  • Investigated changes in mechanical strain in the area of an anastomosis. Worked with mechanical and biomedical engineers and vascular surgeons.
  • 6/89-8/90 Engineer. General Dynamics/Electric Boat Division, Groton, CT.
  • Worked on classified government projects in the field of structures and shielding for nuclear powered surface ships.

 
Funding

    Past
  • Whole Field Deformation Measurements of the Heart with CASI
    Senior Research Associate – (PI: F.P. Chiang, PhD – Dept of Mechanical Engineering)
    Agency: National Science Foundation
    Type: BES-9903516
    Period: 6/99-5/02
    Total Cost: $237, 025
    The focus of this grant is to develop the technique of computer aided speckle interferometry to accurately measure regional functional changes simultaneously over many small regions of the heart. This grant is the direct result of a collaboration I initiated between mechanical engineering and surgery. I was personally responsible for a larger portion of the development and execution of this grant.
     
  • Flow Induced Thromboembolism and the Effect of Implantation Techniques in Mechanical Heart Valves
    Senior Research Associate – (PI: D. Bluestein, PhD – Dept of Biomedical Engineering)
    Agency: American Heart Association
    Type: Scientist Development Grant
    Period: 1/99-12/02
    Total Cost: $259,403
    This grant will advance our understanding of flow-induced thromboembolism in mechanical heart valves to help design better implants, and will offer quantitative information to cardiothoracic surgeons regarding recommended implantation techniques. My contributions include performing aortic valve replacement surgery in sheep and consulting on the physiological and clinical relevance of the model.

    Current
  • A Functional Assessment of Angiogenesis in the Heart
    Principle Investigator
    Agency: New York State Office of Science, Technology & Academic Research
    Type: James D. Watson Investigator Program
    Period: 1/03-12/04
    Total Cost: $200,000
    This proposal will determine, with high spatial resolution, the recovery of mechanical function in the regionally ischemic heart consequent to angiogenesis therapy. In addition, we will use our novel long-term delivery system to overcome a major obstacle in current angiogenesis therapies. Finally, we will determine the location for myocardial injections to result in maximum recovery of function in the ischemic heart.
  • 3-D Imaging Technique for Applications in Anthropometry
    Senior Research Associate – (PI: P. Huang, PhD - Dept of Mechanical Engineering)
    Agency: National Institutes of Health
    Type: PAR-98-047
    Period: 6/01-5/03
    Total Cost: $225,750
    The aim of this project is to develop a novel optical measurement technique for determining changes in chest cavity volume. This grant is largely the result of another collaboration I initiated between mechanical engineering and surgery. I was responsible for the development of some of the specific aims.
  • Drug Delivery Films Designed to Prevent Post-operative Atrial Fibrillation
    Co-Investigator – (PI: W. Chen, PhD - Dept of Biomedical Engineering)
    Agency: Center for Biotechnology
    Type: Innovation Technology Development Grant
    Period: 7/02-6/03
    Total Cost: $40,000
    The aim of this project is to develop a novel biodegradable film for delivering anti-inflammatory agents to the atrium. As we have recently shown that inflammation plays a significant role in post-operative atrial fibrillation, we hypothesize that this film will reduce the incidence of post operative atrial fibrillation.

  •  
    Pending  
  • Using Nanotechnology to Develop an Ibuprofen Embedded Film
    Research Scientist – (P.I. - Stonybrook Tech & Applied Research, Inc)
    Agency: National Institutes of Health
    Type: SBIR (PA)
    Period: 11/02-10/04
    Total Cost: $400,000
    I will be collaborating with investigators from the Department of Chemistry and Stonybrook Technology & Applied Research, Inc. to develop a thin film that will release an anti-inflammatory drug.
  • Cardiac Surgical Ischemia: Biophysical Aspects
    Senior Research Scientist – (PI: I.B. Krukenkamp, MD – Dept of Surgery)
    Agency: National Institutes of Health
    Type: R01
    Period: 12/02-11/07
    Total Cost: $1,881,250
    This translational research will develop an understanding of the biophysical mechanisms and triggers that will direct the development of specific methods to enhance the clinical conduct and outcome of cardiac ischemia for patients who must undergo surgical repair. I was responsible for much of the development of this proposal, including designing and performing pilot studies to begin testing our hypotheses.

 
Publications

Click here to search Glenn Gaudette's PubMed listings

Research Articles:

  • Burns PG, Krukenkamp IB, Caldarone CA, Gaudette GR, Levitsky, S. Intramyocardial assessment of regional ischemia during maximally unloaded contraction. Surgical Forum 1993; 44:230-232.

  • Caldarone CA, Krukenkamp IB, Burns PG, Gaudette GR, Schulman JP, Levitsky S. Does senescence alter myocardial tolerance to blood cardioplegia? Surgical Forum 1993;44:247-249.
  • Caldarone CA, Krukenkamp IB, Burns PG, Misare BD, Gaudette GR, Levitsky S. Ischemia-dependent efficacy of phosphodiesterase inhibition. Annals of Thoracic Surgery 1994; 57:540-545.
  • Burns PG, Krukenkamp IB, Caldarone C, Gaudette GR, Levitsky S. Is the myoprotective ischemic preconditioning response age and/or model dependent? Surgical Forum 1994; 45:212-214.
  • Caldarone CA, Krukenkamp IB, Burns P, Gaudette GR, Levitsky S. Ischemia-dependent efficacy of phosphodiesterase inhibition. Annals of Thoracic Surgery 1994; 57:540-545.
  • Myrmel T, Krukenkamp IB, Caldarone CA, Burns PA, Gaudette G, Levitsky S. Limitations of R-average as an index of left ventricular isovolumic relaxation. Clinical Physiology 1995; 15:447-458.
  • Bukhari EA, Krukenkamp IB, Burns PG, Gaudette GR, Schulman JJ, Al-Fagih MR, Levitsky S. Does Aprotinin increase the myocardial damage in the setting of ischemia and preconditioning. Annals of Thoracic Surgery 1995; 60:307-310.
  • Caldarone CA, Krukenkamp IB, Burns PG, Gaudette GR, Schulman J, Levitsky S. Blood cardioplegia in the senescent heart. Journal of Thoracic and Cardiovascular Surgery 1995; 109:269-74.
  • Burns PG, Krukenkamp IB, Caldarone CA, Gaudette GR, Bukhari EA, Levitsky, S. Does cardiopulmonary bypass alone elicit myoprotective preconditioning? Circulation 1995; 92:II-447-451.
  • Kirvaitis RJ, Krukenkamp IB, Bukhari EA, Gaudette GR, Miyatakae T, Levitsky S. Pinacidil induced hyperpolarized cold blood cardioplegia: a novel myoprotective strategy. Surgical Forum 1995; 46:224-226.
  • Kirvaitis RJ, Krukenkamp IB, Gaudette GR, Miyatake T, Levitsky S; Phorbol-12,13,dibutyrate and pinacidil cardiopleagia: novel forms of myoprotection. Circulation 1996; 94: II-381-II388.
  • Burns PG, Krukenkamp IB, Caldarone CA, Gaudette GR, Kirvaitis RJ, Levitsky, S; Is the preconditioning response conserved in senescent myocardium? Annals of Thoracic Surgery 1996; 61: 925-929.
  • Saltman AE, Krukenkamp IB, Gaudette GR, Levitsky S. Pharmacologic preconditioning with pinacidil provides superior electrophysiological and mechanical preservation for the heart undergoing minimally invasive revascularization. Surgical Forum 1996; 47:295-297.
  • Uematsu M, Gaudette GR, Laurikka JO, Levitsky S, McCully JD. Adenosine-enhanced ischemic preconditioning decreases infarct in the regional ischemic sheep heart. Annals of Thoracic Surgery 1998; 66(2):382-7.
  • Gaudette GR, Horimoto H, Krukenkamp IB. Protection of the heart undergoing minimally invasive surgery: When is ischemic preconditioning detrimental or beneficial? Surgical Forum 1998; 49:214-215.
  • Horimoto H, Gaudette GR, Krukenkamp IB. Nitric oxide is a requisite cofactor to generate adenosine triphosphate-sensitive potassium channel mediated preconditioning. Surgical Forum 1998; 49:202-203.
  • Horimoto H, Saltman AE, Gaudette GR, Krukenkamp IB. Nitric oxide generating beta adrenergic blocker nipradilol preserves post ischemic cardiac function. Annals of Thoracic Surgery 1999; 68:844-849.
  • Aksehirli TO, Valiunas V, Gaudette GR, Matsuyama N, Brink P, Krukenkamp IB. Uncoupling the myocardial gap junctions preconditions the rabbit heart independently of the K+ATP channels. Surgical Forum 1999; 50:100-101.
  • Gaudette GR, Krukenkamp IB, Saltman AE, Horimoto H, Kiraitis RJ, Levitsky S. Preconditioning with PKC and the ATP sensitive potassium channels: a codependent relationship. Annals of Thoracic Surgery 2000; 70:602-608.
  • Saltman AE, Krukenkamp IB, Gaudette GR, Horimoto H, Levitsky S. Pharmacological preconditioning with the adenosine triphosphate-sensitive potassium channel opener pinacidil. Annals of Thoracic Surgery 2000; 70: 595-601.
  • Horimoto H, Gaudette GR, Saltman AE, Krukenkamp IB. The role of nitric oxide, KATP channels, and cGMP in the preconditioning response of the rabbit. Journal of Surgical Research 2000; 92:56-63.
  • Matsuyama N, Leavens JE, McKinnon D, Gaudette GR, Aksehirli TO, Krukenkamp IB. Ischemic but not pharmacological preconditioning requires protein synthesis. Circulation 2000; 102(Supp):III-312-III-318.
  • Saltman AE, Krukenkamp IB, Gaudette GR, Horimoto H, Levitsky S. Amrinone preconditioning in the isolated perfused rabbit heart. Annals of Thoracic Surgery 2000; 70:609-613.
  • Saltman AE, Chandy J, Gaudette GR, Murtha J, Krukenkamp IB. The topical application of antiinflammatory drugs prevents postoperative atrial fibrillation in a canine model. Surgical Forum 2000; 51:76-79.
  • Gaudette GR, Todaro J, Krukenkamp IB, Chiang FP. Computer aided speckle interferometry: a technique for measuring deformation on the surface of the heart. Annals of Biomedical Engineering 2001; 29:775-780.
  • Irie H, Krukenkamp IB, Gaudette GR, Saltman AE, Brinkmann JFF, Abumrad NA, Ibrahimi A. The CD36 protein is an important modulator of ischemic/reperfusion injury in the murine heart. Surgical Forum 2001; 52: 72-74.
  • Horimoto H, Krukenkamp IB, Saltman AE, Gaudette GR, Levitsky S. Nicorandil exerts myocardial preconditioning by opening mitochondrial rather than sarcolemmal ATP-dependent potassium channel. International Journal of Surgical Investigations 2001; 3: 277-285.
  • Gao J. Wymore RS, Gaudette GR, Krukenkamp IB, Cohen IS, Mathias RT. Isoform specific stimulation of the Na/K pump by nanomolar concentrations of Glycosides. Journal of General Physiology 2002; 119: 297-312.
  • Saltman AE, Aksehirli TO, Valiunas V, Gaudette GR, Matsuyama N, Brink P, Krukenkamp IB. Gap junction uncoupling protects the heart against ischemia. Journal of Thoracic and Cardiovascular Surgery 2002; 124: 371-376.
  • Reitano E, Gaudette GR, Krukenkamp IB. Effects of aspirin on the cardioprotective benefits of arachidonic acid in ischemic preconditioning. International Journal of Cardiovascular Medicine and Science (In press, 2002).
  • Irie H, Krukenkamp IB, Gaudette GR, Saltman AE, Brinkmann JFF, Abumrad NA, Ibrahimi A. The CD36/FAT protein is an important mediator of ischemic tolerance in the murine heart. American Journal of Physiology (submitted, 2002).
  • Gaudette GR, Lense M, Todaro J, Azeloglu E, Keene L, Saltman AE, Krukenkamp IB, Chiang FP. Effects of ischemia on epicardial deformation in the passive rabbit heart. Journal of Biomedical Engineering (submitted, 2001).
  • Saltman AE, Gaudette GR, Tselentakis EV, Woodford EJ, Chandy J, Krukenkamp IB. The topical application of anti-inflammatory drugs prevents postoperative atrial fibrillation in a canine model. Journal of Thoracic and Cardiovascular Surgery (submitted, 2002).
  • Gao J, Mathias RT, Cohen IS, Zuckerman J, Gaudette GR, Irie H, Saltman AE, Krukenkamp IB. Ischemic preconditioning preserves the normal current-voltage relationship in isolated rabbit ventricular myocytes. Circulation Research (submitted, 2002).
  • Gaudette GR, Azeloglu E, Todaro J, Saltman AE, Krukenkamp IB, Chiang FP. Determination of regional function with high spatial resolution in the beating heart. (in progress).

Conference Proceedings:

  • Gaudette GR, Chiang FP, Todaro J, Krukenkamp IB. Using computer aided speckle interferometry to measure pressure effects on the heart. Proceeds from the 1999 ASME Pressure Vessels and Piping Conference 1999; PVP-Vol. 392:309-318.
  • Gaudette GR, Chiang FP, Todaro J, Krukenkamp IB. A novel technique for measuring regional deformation with high spatial resolution in the beating heart. Proceeds from the ASME 1999 International Mechanical Engineering Congress and Exposition – 1999 Advances in Biomedical Engineering 1999; BED-Vol 43:239-240.
  • Gaudette GR, Todaro J, Guan E, Krukenkamp IB, Chiang FP. Using computer aided speckle interferometry to measure deformation in the non-beating perfused rabbit heart. Proceeds from the ASME 2000 International Mechanical Engineering Congress and Exposition – 2000 Advances in Biomedical Engineering 2000; BED-Vol.48: 125-126.
  • Gaudette GR, Todaro J, Azeloglu EA, Krukenkamp IB, Chiang FP. Determination of regional stroke work with high spatial resolution in the isolated rabbit heart. Proceeds from the ASME 2001 International Mechanical Engineering Congress and Exposition – 2001 Advances in Biomedical Engineering 2001.

Book Chapters

  • Gaudette GR, Azeloglu E, Todaro J, Keene L, Krukenkamp IB, Chiang FP. The application of speckle metrology to the heart. In Recent Advance in Experimental Mechanics. E. E. Gdoutos, Editor; Kluwer Academic Publishers; 2002.

Abstracts

  • Caldarone CA, Krukenkamp IB, Burns PG, Gaudette GR, Myrmel T, Levitsky S; Single beat mitral occlusion in the in vivo ejecting heart: the trisection of myocardial mechanics. Journal of the American College of Cardiologist 1994; 23:164A.
  • Burns PG, Krukenkamp IB, Caldarone CA, Gaudette GR, Levitsky, S; Redefining regional myocardial function. Journal of the American College of Cardiologist 1994; 23:164A.
  • Burns PG, Krukenkamp IB, Caldarone CA, Gaudette GR, Levitsky, S; Regional internal cardiac work is dependent on coronary blood flow in maximally unloaded contraction. The FASEB Journal 1994; 8:A592.
  • Burns PG, Krukenkamp IB, Caldarone CA, Gaudette GR, Bukhari EA, Levitsky, S; Does cardiopulmonary bypass alone elicit myoprotective preconditioning? Circulation 1994; 90:I-423.
  • Bukhari EA, Krukenkamp IB, Burns PG, Gaudette GR, Schulman JJ, Al-Fagih MR, Levitsky S; Does aprotinin increase the myocardial damage in the setting of ischemia and preconditioning. Society of Thoracic Surgeons, Program of the Thirty-first Annual Meeting, 1995; 68-9.
  • Kirvaitis RJ, Krukenkamp IB, Gaudette GR, Miyatake T, Levitsky, S; Phorbol-12,13-dibutyrate and pinacidil cardioplegia: novel forms of myoprotection. Circulation 1995; 92(8): I-513-4.
  • Kirvaitis RJ, Krukenkamp IB, Khaw B, Burns PG, Gaudette GR, Petrov A, Goldfaden A, Schulman J, Levitsky S. Ischemically preconditioned myocardium is vulnerable to reperfusion induced injury. Journal of the American College of Cardiologist 1996; 27:92A.
  • Kirvaitis RJ, Krukenkamp IB, Bukhari EA, Gaudette GR, Miyatake T, Al-Fagih MR, Levitsky S; The effects of aprotinin and amicar on preconditioning in regional ischemia. The FASEB Journal 1996; 10(3): A323.
  • Gaudette GR, Krukenkamp IB, Burns PG, Caldarone CA, Levitsky S; Quantifying regional coronary venous drainage during ischemia and reperfusion. The FASEB Journal 1996; 10(3): A35.
  • Saltman AE, Krukenkamp IB, Gaudette GR, Levitsky S. Amrinone preconditioning provides electrophysiological and mechanical protection equivalent to ischemic preconditioning. Circulation 1996; 94(8): I-114.
  • Saltman AE, Krukenkamp IB, Gaudette GR, Levitsky S. Phenylephrine reverses the vasodilatory effect of potassium channel openers yet preserves their preconditioning properties. Circulation 1996; 94(8): I-415.
  • Saltman AE, Krukenkamp IB, Gaudette GR, Levitsky S. The effect of beta receptor manipulation on ischemic preconditioning. FASEB 1997; 11(3): A72.
  • Gaudette GR, Krukenkamp IB, Saltman AE, Levitsky S. Dobutamine preconditioning reduces infarct size, but has detrimental mechanical and electrical effects. FASEB 1997; 11(3): A73.
  • Horimoto H, Krukenkamp IB, Saltman AE, Gaudette GR, Levitsky S. The L-arginine-nitric oxide pathway is involved in the preconditioning response of rabbit hearts treated with nicorandil. Circulation 1997; 96: I-3852.
  • Gaudette GR, Chiang FP, Todaro J, Krukenkamp IB. A novel technique for measuring epicardial deformation with high spatial resolution. Biophysical Journal 1999; 76: A309.
  • Gao J, Wang Y, Mathias R, Cohen I, Krukenkamp IB, Baldo G, Gaudette GR, Zuckerman J. Low concentrations of dihydroouabain (DHO) stimulates the Na/K pump in human, canine, and guinea pig cardiac myocytes. Biophysical Journal 1999; 76: A309.
  • Wu J-Y, Cohen IS, Gaudette GR, Krukenkamp IB, Zuckerman J, Yu H. Is If the only pacemaker current in mammalian atrial myocytes? Biophysical Journal 1999; 76: A309.
  • Matsuyama N, Leavens JE, McKinnon D, Gaudette GR, Aksehirli TO, Krukenkamp IB. Ischemic but not pharmacological preconditioning requires protein synthesis. Circulation 1999; 100: I-388.
  • Horimoto H, Saltman AE, Gaudette GR, Nakai Y, Sasaki S, Krukenkamp IB. The nitric oxide generating–blocker nipradilol preconditions the heart through a NO-cyclic GMP-dependent mechanism. Circulation 1999; 100: I-596.
  • Gaudette GR, Todaro J, Chiang FP, Krukenkamp IB. Assessing ventricular mechanics with computer aided speckle interferometry. Annals of Biomedical Engineering 2000; 28: S-58.
  • Mieno S, Horimoto H, Sawa Y, Nakai Y, Nakahara K, Gaudette GR, Krukenkamp IB. Ischemic preconditioning on failed heart does not afford myoprotection due to downregulation of beta-adrenergic receptor. Circulation 2000; 102 (18): II-580.
  • Tracz M, Gaudette GR, Shulimovich M, Murtha J, Matsuyama N, Krukenkamp IB. Bcl-2 expression is upregulated in ischemic preconditioning. Circulation 2000; 102 (18): II-581.
  • Gao J, Cohen IS, Mathias RT, Gaudette GR, Krukenkamp IB. Metabolic inhibition by NaCN does not activate KATP current in guinea pig ventricular myocytes. Biophysical Journal 2001; 80(1): 637.
  • Gaudette GR, Todaro J, Krukenkamp IB, Chiang FP. Measuring epicardial deformation in the regionally ischemic rabbit heart. Annals of Biomedical Engineering 2001; 29: S-80.
  • Irie H, Ibrahimi A, Abumrad N, Gaudette GR, Saltman AE, Goodman MA, Krukenkamp IB. Fatty acid transport via CD36 is an important mediator of ischemic tolerance in the murine heart. Circulation 2001; 104: II-474.
  • Gaudette GR, Gao J, Cohen IS, Mathias RT, Krukenkamp IB. Ischemic preconditioning protects the heart from membrane current changes due to ischemia. Journal of the American College of Cardiology 2002; 39: 323A.
  • Tselentakis EV, Gaudette GR, Saltman AE. Inflammation depresses electrical conductance in normal heart tissue. Annals of Biomedical Engineering 2002; in press.
  • Gaudette GR, Azeloglu AE, Oleszak L, Ferreri SL, Saltman AE, Krukenkamp IB, Chiang FP. Determination of myocardial function with high spatial resolution in the regionally ischemic beating rabbit heart. Annals of Biomedical Engineering 2002; in press.
  • Gaudette GR, Azeloglu EA, Saltman AE, Krukenkamp IB, Chiang FP. Determination of regional function with high spatial resolution in the regionally ischemic heart. Circulation 2002; in press.
  • Irie H, Gao J, Gaudette GR, Cohen IS, Mathias RT, Krukenkamp IB. Both metabolic inhibition and mitochondrial KATP channel opening are myoprotective and initiate a compensatory sarcolemmel outward membrane current. Circulation 2002; in press.
  • Saltman AE, Tselentakis EV, Gaudette GR, Krukenkamp IB. Inflammation and Atrial Fibrillation: Arachidonic acid decreases atrial conduction velocity in a fiber orientation dependent manner. Circulation 2002; in press.

 
Patents

  • Biodegradable Polymer Device for Preventing Atrial Fibrillation (in progress – with W. Chen, Y. Yun, A. Saltman, H. Jiang). This device will release anti-inflamatory agents to specific tissues of interest.

 
Courses

  • BME 440 Design in Biomedical Engineering
  • BME 441 Senior Design Project (In Development)